Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Combination with Palbociclib and Endocrine Therapy for ER+ Advanced Breast Cancer (ABC) at the 2021 San Antonio Breast Cancer Symposium
78% ORR in 3rd line patients and 63% ORR overall in patients treated with three…
BOMESI Foundation Opens Fifth Accelerator Cohort For Diverse-Owned Media Publishers And Creators
Ynvisible Advances Commercial Program with Sapphiros, Announces CFO Appointment and Adoption of Semi-Annual Financial Reporting
Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage
Syntheia Signs Definitive Agreement for Sale of Call Center Assets and Announces Shares for Debt Transaction